Catalog Number AASME08060 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problem
Restenosis (4576)
|
Event Date 03/09/2022 |
Event Type
Injury
|
Event Description
|
It was reported through a clinical trial, that approximately one year and eleven months post stent placement procedure in the left a.Iiliaca externa via ipsilateral approach, patient was diagnosed with in-stent re-stenosis.The current status of the patient is unknown.
|
|
Manufacturer Narrative
|
The catalog number identified has not been cleared in the us but is similar to the covera vascular covered stent products that are cleared in the us.The pro code and 510k number for the covera vascular covered stent products is identified.Concomitant medical products: as the lot number for the device was provided, a manufacturing review will be performed.The sample was not returned to the manufacturer for inspection/evaluation.Therefore, the investigation of the reported event is inconclusive.Based upon the available information, the definitive root cause for this event is unknown.The instructions for use (ifu) is adequate for the reported device/patient code(s) and provides general instructions for use, as well as warnings, precautions and potential complications associated with the device.Upon receipt of new or additional information, a follow-up report will be submitted as applicable.(expiry date: (b)(6) 2021).
|
|
Manufacturer Narrative
|
H10: the catalog number identified in section d4 has not been cleared in the us but is similar to the covera vascular covered stent products that are cleared in the us.The pro code and 510k number for the covera vascular covered stent products is identified in d2 and g4.H10: manufacturing review: the lot history records of this lot were reviewed with special attention to the manufacturing and inspection of this product and the product was found to have met the specification prior to shipment.Investigation summary: the sample was not returned for evaluation and image was not provided.Therefore, the investigation is inconclusive for the reported issue.A definitive root cause could not be determined based upon the available information.Labeling review: in reviewing the relevant labeling for this product the potential issue was found addressed.Under potential complications and adverse events the instruction for use state: 'restenosis (.) thrombus'.In regards to pta the instruction for use state: 'pre-dilate the stenosis with a pta balloon catheter of appropriate length and diameter for the lesion to be treated.' and 'post dilate the covered stent with an angioplasty balloon sized appropriately as to ensure complete wall apposition to the reference vessel.Avoid balloon dilation in the healthy, non-stenosed segment of the vessel.'.Holding and handling of system was found described, in particular the instruction for use state: 'do not touch the distal catheter assembly (i.E.The dark brown catheter segment) during covered stent deployment since this may interfere with covered stent deployment and may lead to misplacement'.H10: d4 (expiry date: 12/2021), g3.H11: g1, h6 (method).H11: section a through f ¿ the information provide by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
|
|
Event Description
|
It was reported through a clinical trial, that approximately one year and eleven months post stent placement procedure in the left a.Iiliaca externa via ipsilateral approach, patient was diagnosed with in-stent re-stenosis.The current status of the patient is unknown.
|
|
Search Alerts/Recalls
|
|